823 Repurposing CD26/DPP4 inhibitors to enhance immunotherapy response in pancreatic ductal adenocarcinoma
Main Authors: | , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2023-11-01
|
Series: | Journal for ImmunoTherapy of Cancer |
_version_ | 1797383228412133376 |
---|---|
author | Thomas Mace Gregory B Lesinski Chrystal M Paulos Michael Ware Olatunji Alese Juan Sarmiento Shishir Maithel Maggie Phillips Megan M Wyatt Natalie K Horvat Jacklyn Hammons Bassel FEl Reyes |
author_facet | Thomas Mace Gregory B Lesinski Chrystal M Paulos Michael Ware Olatunji Alese Juan Sarmiento Shishir Maithel Maggie Phillips Megan M Wyatt Natalie K Horvat Jacklyn Hammons Bassel FEl Reyes |
author_sort | Thomas Mace |
collection | DOAJ |
first_indexed | 2024-03-08T21:17:53Z |
format | Article |
id | doaj.art-ec528f048f7847a9b25e2cd153a50053 |
institution | Directory Open Access Journal |
issn | 2051-1426 |
language | English |
last_indexed | 2024-03-08T21:17:53Z |
publishDate | 2023-11-01 |
publisher | BMJ Publishing Group |
record_format | Article |
series | Journal for ImmunoTherapy of Cancer |
spelling | doaj.art-ec528f048f7847a9b25e2cd153a500532023-12-21T14:40:08ZengBMJ Publishing GroupJournal for ImmunoTherapy of Cancer2051-14262023-11-0111Suppl 110.1136/jitc-2023-SITC2023.0823823 Repurposing CD26/DPP4 inhibitors to enhance immunotherapy response in pancreatic ductal adenocarcinomaThomas Mace0Gregory B Lesinski1Chrystal M Paulos2Michael Ware3Olatunji Alese4Juan Sarmiento5Shishir Maithel6Maggie Phillips7Megan M Wyatt8Natalie K Horvat9Jacklyn Hammons10Bassel FEl Reyes113The Ohio State University, Columbus, OH, USAEmory University, Atlanta, GA, USAEmory University, Atlanta, GA, USA2NeoImmuneTech, Inc., Snellville, GA, USA4Winship Cancer Institute at Emory University, Atlanta, GA, USA1Emory University, Atlanta, GA, USA1Emory University, Atlanta, GA, USA1Emory University, Atlanta, GA, USAEmory University, Atlanta, GA, USAEmory University, Atlanta, GA, USAEmory University, Atlanta, GA, USA5University of Alabama at Birmingham Medical Center, Birmingham, AL, USA |
spellingShingle | Thomas Mace Gregory B Lesinski Chrystal M Paulos Michael Ware Olatunji Alese Juan Sarmiento Shishir Maithel Maggie Phillips Megan M Wyatt Natalie K Horvat Jacklyn Hammons Bassel FEl Reyes 823 Repurposing CD26/DPP4 inhibitors to enhance immunotherapy response in pancreatic ductal adenocarcinoma Journal for ImmunoTherapy of Cancer |
title | 823 Repurposing CD26/DPP4 inhibitors to enhance immunotherapy response in pancreatic ductal adenocarcinoma |
title_full | 823 Repurposing CD26/DPP4 inhibitors to enhance immunotherapy response in pancreatic ductal adenocarcinoma |
title_fullStr | 823 Repurposing CD26/DPP4 inhibitors to enhance immunotherapy response in pancreatic ductal adenocarcinoma |
title_full_unstemmed | 823 Repurposing CD26/DPP4 inhibitors to enhance immunotherapy response in pancreatic ductal adenocarcinoma |
title_short | 823 Repurposing CD26/DPP4 inhibitors to enhance immunotherapy response in pancreatic ductal adenocarcinoma |
title_sort | 823 repurposing cd26 dpp4 inhibitors to enhance immunotherapy response in pancreatic ductal adenocarcinoma |
work_keys_str_mv | AT thomasmace 823repurposingcd26dpp4inhibitorstoenhanceimmunotherapyresponseinpancreaticductaladenocarcinoma AT gregoryblesinski 823repurposingcd26dpp4inhibitorstoenhanceimmunotherapyresponseinpancreaticductaladenocarcinoma AT chrystalmpaulos 823repurposingcd26dpp4inhibitorstoenhanceimmunotherapyresponseinpancreaticductaladenocarcinoma AT michaelware 823repurposingcd26dpp4inhibitorstoenhanceimmunotherapyresponseinpancreaticductaladenocarcinoma AT olatunjialese 823repurposingcd26dpp4inhibitorstoenhanceimmunotherapyresponseinpancreaticductaladenocarcinoma AT juansarmiento 823repurposingcd26dpp4inhibitorstoenhanceimmunotherapyresponseinpancreaticductaladenocarcinoma AT shishirmaithel 823repurposingcd26dpp4inhibitorstoenhanceimmunotherapyresponseinpancreaticductaladenocarcinoma AT maggiephillips 823repurposingcd26dpp4inhibitorstoenhanceimmunotherapyresponseinpancreaticductaladenocarcinoma AT meganmwyatt 823repurposingcd26dpp4inhibitorstoenhanceimmunotherapyresponseinpancreaticductaladenocarcinoma AT nataliekhorvat 823repurposingcd26dpp4inhibitorstoenhanceimmunotherapyresponseinpancreaticductaladenocarcinoma AT jacklynhammons 823repurposingcd26dpp4inhibitorstoenhanceimmunotherapyresponseinpancreaticductaladenocarcinoma AT basselfelreyes 823repurposingcd26dpp4inhibitorstoenhanceimmunotherapyresponseinpancreaticductaladenocarcinoma |